comparemela.com

Latest Breaking News On - Pharmaceutical benefits advisory board - Page 1 : comparemela.com

Newborn screening: The postcode lottery saving some Aussie babies but not others

Push to get $3 5m drug approved to save kids lives

Push to get $3 5m drug approved to save kids lives
byronnews.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from byronnews.com.au Daily Mail and Mail on Sunday newspapers.

Push to get $3 5m drug approved to save kids lives | Fraser Coast Chronicle

Push to get $3 5m drug approved to save kids lives | Fraser Coast Chronicle
frasercoastchronicle.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from frasercoastchronicle.com.au Daily Mail and Mail on Sunday newspapers.

Push to get $3 5m drug approved to save kids lives

Push to get $3 5m drug approved to save kids lives
warwickdailynews.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from warwickdailynews.com.au Daily Mail and Mail on Sunday newspapers.

Push to get $3 5m drug approved to save kids lives

Health by Jane Hansen Premium Content Subscriber only It is one of the most expensive drugs to ever hit the market, but at $3.5 million per one-off dose, it can mean the difference between life and death for a baby born with spinal muscular atrophy (SMA). Zolgensma, a gene therapy, is approved by the Therapeutic Good Administration (TGA) but is currently facing a Pharmaceutical Benefits Advisory Board (PBAC) decision on whether to list it for subsidy on the Pharmaceutical Benefits Scheme. One in 35 people carry the gene mutation for SMA. SMA leads to paralysis, breathing difficulties and death within months for babies born with Type I, the most serious form. About 30 babies a year, an entire classroom of children, are born with SMA each year.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.